Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis
Combined treatments employing lower concentrations of different drugs are used and studied to develop new and more effective anticancer therapeutic approaches. The combination therapy could be of great interest in the controlling of cancer. Regarding this, our research group has recently shown that...
Main Authors: | Chiara Tupini, Matteo Zurlo, Jessica Gasparello, Irene Lodi, Alessia Finotti, Thomas Scattolin, Fabiano Visentin, Roberto Gambari, Ilaria Lampronti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/5/1332 |
Similar Items
-
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
by: Maria Teresa Di Martino, et al.
Published: (2022-03-01) -
Genistein Promotes Skeletal Muscle Regeneration by Regulating miR-221/222
by: Linyuan Shen, et al.
Published: (2022-11-01) -
Expression of miR⁃21, miR⁃221, and miR⁃222 in exosomes of CAL27 tongue squamous cell carcinoma cells
by: HUANG Wenxi, et al.
Published: (2018-04-01) -
Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis
by: Gloria Ravegnini, et al.
Published: (2019-07-01) -
Post-transcriptional Regulation of PCSK9 by miR-191, miR-222, and miR-224
by: Parisa Naeli, et al.
Published: (2017-11-01)